ema prac naion semaglutide very rare side effect 2025 may cause blindness—US study warning adds to growing debate on Do GLP-1 Medications Cause Eye

The duration of nausea can vary on Wegovy

Wischmeyer lost 60 pounds and reversed her hypertension After getting a jump-start with semaglutide, Wischmeyer now has more energy for healthier habits

The added GIP receptor activation (glucose-dependent insulinotropic polypeptide) brings a second metabolic dimension, further enhancing insulin sensitivity, supporting fat metabolism in adipose tissue, and amplifying the appetite-reducing effects of GLP-1 activation through complementary neural pathways

This is intended to serve as a foundation. However, he says we need prospective studies, including large ones and those with control subjects